FIELD: medicine.
SUBSTANCE: invention refers to molecular biology, genetic engineering and virology. What is presented is a method for producing a preparation containing the viral antigens, involving a) cell inoculation with an infectious in the fluid, b) reproduction of the above virus in the above cells, c) collection of the above reproduced virus, d) inactivation of the above collected virus, and e) treatment of the above inactivated virus with a detergent to produce the preparation containing the viral antigens.
EFFECT: method may be used in medicine and pharmacology to produce vaccines.
21 cl, 1 dwg, 2 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR OBTAINING A TETRAVALENT VACCINE FOR THE PREVENTION OF INFLUENZA | 2020 |
|
RU2754398C1 |
TWO-STAGE TEMPERATURE PROFILE OF VIRAL CULTIVATION | 2008 |
|
RU2476594C2 |
METHOD OF OBTAINING VIRAL ANTIGEN AND VACCINES | 2012 |
|
RU2565827C2 |
METHOD OF REPLICATION OF INFLUENZA VIRUS IN CULTURE | 2007 |
|
RU2491339C2 |
RESPIRATORY-SYNCYTIAL VIRUS SUBUNIT VACCINE PREPARATION | 1997 |
|
RU2243234C2 |
INACTIVATED VACCINES OF RESPIRATORY-SYNTYTIAL VIRUS | 1994 |
|
RU2142817C1 |
METHOD FOR PREPARING COMBINED BIVALENT, TISSUE-CULTURE, INACTIVATED, CONCENTRATED, PURIFIED VACCINE FOR PREVENTING HEMORRHAGIC FEVER AND RENAL SYNDROME | 2009 |
|
RU2445117C2 |
METHOD OF VIRUS TREATMENT BY ULTRACENTRIFUGATION IN SUGAR CONCENTRATION GRADIENT (VERSIONS) | 2008 |
|
RU2503719C2 |
METHOD OF OBTAINING INACTIVATED VACCINE AGAINST COVID-19 AND VACCINE OBTAINED BY METHOD | 2023 |
|
RU2810740C1 |
VIRUS VACCINE AND METHODS FOR PRODUCTION THEREOF | 2014 |
|
RU2706693C2 |
Authors
Dates
2013-10-27—Published
2008-08-28—Filed